Genome Engineering @CRISPR-Tech
Turn on notifications
Flag as spam
"Dear Investors, Here is your monthly update for May 2018 The CRISPR-Tech CopyFund is a thematic investment portfolio, which means its strategy is based on a particular investment theme, in this case selecting bio-tech or pharmateutical stocks focusing on CRISPR-Technology. This CopyFund’s portfolio is built by eToro’s investment committee. The S&P500 is currently up 2% this year. This CopyFund’s portfolio is currently up 4%, outperformingthe index by 100%. This month was a top performing month for the CopyFund in terms of profit, closing 8% higher for the month. This CopyFund is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. The risk increased for this CopyFund over last month was due to quarterly earnings reports among the selected stocks in the portfolio and general volatility among the technology sector in the US. Increased risk, can mean larger swings both ways in terms of profit and loss. Please bear this in mind. If you are planning to add funds to your existing investment, you can do so by closing your current investment and reopen it with your desired investment amount. The rebalancing for this CopyFund takes place upon the discretion of the investment committee and any communications about this will be made in advance. Please remember past performance is not indicative of any future performance. <a href="/markets/ntla" class="e-link">$NTLA (Intellia Therapeutics Inc)</a>, <a href="/markets/mrk" class="e-link">$MRK (Merck)</a>, <a href="/markets/clls" class="e-link">$CLLS (Cellectis SA)</a>, <a href="/markets/edit" class="e-link">$EDIT (Editas Medicine Inc)</a>, <a href="/markets/a" class="e-link">$A (Agilent Technologies Inc)</a>, <a href="/markets/sgmo" class="e-link">$SGMO (Sangamo Biosciences Inc)</a>, $REGN" ... Show More